When will Thomson Medical report earnings and why does it matter for A50.SI stock?

Thomson Medical reports results on **06 Feb 2026**. The release matters because guidance and margin commentary can move the stock from the current **S$0.06** level and affect refinancing and dividend prospects.

What is Meyka AI's view and grade for A50.SI stock?

Meyka AI rates A50.SI with a score out of 100 at **58.20**, Grade **C+ (HOLD)**. The grade weighs sector, growth, metrics and consensus and is informational, not financial advice.

What are realistic price targets for A50.SI stock after earnings?

Scenario targets: bull **S$0.07** (+16.67%), base **S$0.06** (0.00%), bear **S$0.05** (-16.67%). These reflect current range, forecasts and liquidity considerations.

Which financial ratios should investors check post-report for A50.SI stock?

Focus on **debt/equity (2.38)**, interest coverage (**0.28**), price/book (**3.32**) and operating cash flow. Improvement in coverage and cash flow is needed to ease leverage risk.

SG Stocks

After-hours A50.SI Thomson Medical (SES) earnings due 03 Feb 2026: guidance watch

ByDanny Kontos February 3, 2026February 3, 2026

Thomson Medical Group Limited’s A50.SI stock is trading at S$0.06 in after-hours trade as investors position ahead of the group’s earnings announcement scheduled for 06 Feb 2026. The stock opened at S$0.06, closed the regular session at S$0.06, and showed a -1.64% intraday move on volume of 4,272,400.00 shares. With a year high of S$0.07 and year low of S$0.04, the upcoming results and any guidance change are the primary near-term catalysts for traders and dividend-focused investors in Singapore (SES)